相关实验视频

Updated: May 11, 2025

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

乳红细胞瘤和帕拉格林瘤:当前的管理策略

Reuben Ben-David¹, Ahmed Eraky¹, Reza Mehrazin¹

¹Department of Urology, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Pl, New York, NY 10029, USA.

The Urologic clinics of North America

|April 18, 2025

概括

乳色细胞瘤和偏角细胞瘤 (PPGLs) 是一种罕见的瘤. 诊断和治疗方面的进步,包括手术和新型疗法,改善了患者的治疗结果,但全球范围内的治疗方式各不相同.

科学领域:

内分泌学在内分泌学.
在瘤学瘤学.
手术病理学手术病理学

背景情况:

乳色细胞瘤和偏角细胞瘤 (PPGLs) 是一种罕见的神经内分泌瘤,起源于克罗马芬细胞.
这些瘤带来了复杂的临床挑战,包括恶性瘤的可能性和各种激素活性.
由于PPGL的异质性,目前的管理依赖于多学科的方法.

研究的目的:

审查最近在染细胞瘤和偏角细胞瘤的诊断和管理方面的进展.
突出生物化学测试,成像模式,遗传咨询和外科手术技术的进展.
讨论转移性疾病的新兴治疗策略以及全球医疗保健获取的挑战.

主要方法:

关于PPGL诊断和治疗的最新研究的综合文献综述.
分析当前的指导方针和生物化学测试,成像技术 (如MIBG,DOTATATE PET) 和基因测试的新兴研究.
评估手术方法,包括微创和开放技术.
对新型全身疗法的审查,包括向药物和放射性干疗法.

主要成果:

通过增强的生物化学测试和先进的成像技术实现了诊断准确性的显著改进.
最少侵入性手术越来越受欢迎,为患者提供更好的治疗结果,尽管对复杂病例而言,开放式手术仍然至关重要.
新兴的治疗方法,如向疗法和放射性连接体疗法,对转移的PPGLs显示出希望.
在获得先进的诊断和治疗选择方面,全球的差异仍然存在.

结论:

综合的诊断和治疗策略显著改善了患有染细胞瘤和偏角细胞瘤的患者的治疗结果.
多学科护理和持续的研究对于解决这些罕见瘤的复杂性和优化管理至关重要.
解决医疗保健获取方面的全球不平等问题对于全球公平的患者护理至关重要.

关键词:

上腺染细胞瘤是什么额外上腺染细胞瘤神经内分泌瘤的神经内分泌瘤抛售者可能会变得更强大.染细胞瘤 (Pheochromocytoma) 是一种细胞瘤.

更多相关视频

Surgical Technique for Superior Cervical Ganglionectomy in a Murine Model

Surgical Technique for Superior Cervical Ganglionectomy in a Murine Model

Published on: December 2, 2022

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

相关概念视频

Adrenergic Agonists: Therapeutic Uses

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...

Drugs Acting on Autonomic Ganglia: Blockers

Drugs Acting on Autonomic Ganglia: Blockers

Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...

Adrenergic Agonists: Direct-Acting Agents

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...